On June 16, 2017 107,330,210 Idorsia shares were listed on SIX. Furthermore, shares issued through the conversion of the first tranche of the convertible loan provided by Cilag Holding AG, an indirect subsidiary of Johnson & Johnson (CHF 135.4 million converting into 11,793,220 Idorsia shares (“Authorized Shares”) were listed on June 20, 2017.

On July 13, 2018 the Group privately placed 11,912,000 new registered shares of CHF 0.05 par value from existing authorized capital at CHF 25.62 per new share receiving gross proceeds of CHF 305 million through an accelerated bookbuilding.

Concurrently to the private placement of new shares, the Group issued CHF 200 million of senior unsecured convertible bonds (“the Bonds”) on July 17, 2018. The Bonds mature on July 17, 2024 and are convertible into 5.9 million registered shares of the Group, sourced from existing conditional share capital, on or after August 27, 2018. The Bonds have a coupon of 0.75% and a conversion price of CHF 33.95, corresponding to a conversion premium of 32.5% above the bookbuilding price of the privately placed newly issued shares.

On May 22, 2020 the Group privately placed 11 million new registered shares of CHF 0.05 par value from existing authorized share capital at CHF 30 per new share receiving gross proceeds of CHF 330 million, by way of an accelerated book-building process.

Idorsia Ltd is part of the following indices: SPI, SPIEX, SXSLI, SXI Life Sciences, and SXI Bio+Medtech.

Idorsia is traded under the following symbols: Reuters IDIA.S / Bloomberg IDIA:SW.

Key Share Data

As of March 31, 2020
Shares outstanding 131.3 million
Closing share price CHF 25.20
Market capitalization CHF 3.3 billion
52-week high CHF 33.88
52-week low CHF 17.57
YTD price change CHF -4.74 (-15.83%)
HY average daily volume 587,645 shares
Free float 74.5 million shares

We will update this information quarterly.

Major Shareholders

As of March 31, 2020

Shareholder Position

Jean-Paul & Martine Clozel

 > 25%

Johnson & Johnson

 > 5%

Rudolf Maag

 > 5%

Georges Gaspard / David Coti

 > 3%

Artisan Partners

 > 3%

How To Buy Stock

Idorsia shares are traded on the SIX Swiss Stock Exchange. Investors wishing to become a shareholder in Idorsia should contact their local bank with the following information:

   
Reuters / Bloomberg: IDIA.S / IDIA:SW
Exchange: SIX, Switzerland
ISIN: CH0363463438
Swiss security number: 36 346 343


Bank staff will then be able to use this information to execute the transaction.

How To Register Shares

As part of our continued efforts towards good corporate governance we encourage shareholders to exercise their voting rights at the Annual General Meeting (AGM) of Idorsia Ltd.

The registration of shares is not mandatory under Swiss law. Therefore, registered shares are not automatically registered in our Share Register.

Idorsia has mandated areg.ch to administer its Share Register. Investors wishing to register their shares are kindly asked to contact their prime custodian (e.g. your banker or broker) to request a share registration form. After completing the form, your custodian will send it to areg.ch who will then take care of the registration. The custodian will receive a confirmation directly from areg.ch once the registration has taken place.

"I find my work inspirational because every day I invent something new."

Lab Head, Chemistry